Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

KB 130015

Known as: 2-methyl-3-(3,5-diiodo-4-carboxymethoxybenzyl)benzofuran, KB-130015, KB130015 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2010
2010
Human ether à go-go related gene (hERG1) potassium channels underlie the repolarizing I(Kr) current in the heart. Since they are… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2007
2007
2-methyl-3-(3,5-diiodo-4-carboxymethoxybenzyl)benzofuran (KB130015) has been developed to retain the antiarrhythmic properties of… Expand
Is this relevant?
2006
2006
KB130015 [KB; 2-methyl-3-(3,5-diiodo-4-carboxymethoxybenzyl)benzofuran] is a novel amiodarone derivative designed to retain the… Expand
Is this relevant?
2005
2005
BACKGROUND AND PURPOSE Vagus-induced atrial fibrillation is of particular clinical interest. The muscarinic potassium current I(K… Expand
Is this relevant?
Review
2005
Review
2005
KB130015 [KB; 2-methyl-3-(3,5-diiodo-4-carboxymethoxybenzyl)benzofuran] is a novel amiodarone derivative designed to retain the… Expand
  • figure 1
  • figure 3
  • figure 4
  • figure 6
  • figure 7
Is this relevant?
2004
2004
2-Methyl-3- (3,5-diiodo-4-carboxymethoxybenzyl) benzofuran (KB130015; KB), a novel compound derived from amiodarone, has been… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
Review
2003
Review
2003
KB130015 (KB015), a new drug structurally related to amiodarone, has been proposed to have antiarrhythmic properties. In contrast… Expand
Is this relevant?
2003
2003
1. We have studied the acute cardiac electrophysiological effects of KB130015 (KB), a drug structurally related to amiodarone… Expand
Is this relevant?
2003
2003
-Methyl-3-(3,5-diiodo-4-carboxymethoxybenzyl)benzofuran (KB130015 or KB) is a new drug, structurally related to amiodarone and to… Expand
  • figure 1
  • figure 2
  • figure 5
  • figure 6
  • figure 7
Is this relevant?